全文获取类型
收费全文 | 9989402篇 |
免费 | 653008篇 |
国内免费 | 156731篇 |
专业分类
耳鼻咽喉 | 130742篇 |
儿科学 | 281411篇 |
妇产科学 | 231611篇 |
基础医学 | 1238650篇 |
口腔科学 | 264027篇 |
临床医学 | 1009202篇 |
内科学 | 1663189篇 |
皮肤病学 | 203495篇 |
神经病学 | 722181篇 |
特种医学 | 375899篇 |
外国民族医学 | 1661篇 |
外科学 | 1323692篇 |
综合类 | 711526篇 |
现状与发展 | 513篇 |
一般理论 | 3725篇 |
预防医学 | 794950篇 |
眼科学 | 228290篇 |
药学 | 863429篇 |
2891篇 | |
中国医学 | 211722篇 |
肿瘤学 | 536335篇 |
出版年
2022年 | 80791篇 |
2021年 | 180055篇 |
2020年 | 142136篇 |
2019年 | 145585篇 |
2018年 | 177799篇 |
2017年 | 158431篇 |
2016年 | 153321篇 |
2015年 | 193730篇 |
2014年 | 279686篇 |
2013年 | 370839篇 |
2012年 | 523443篇 |
2011年 | 567933篇 |
2010年 | 385132篇 |
2009年 | 346279篇 |
2008年 | 483662篇 |
2007年 | 503932篇 |
2006年 | 481025篇 |
2005年 | 442658篇 |
2004年 | 389382篇 |
2003年 | 360553篇 |
2002年 | 331555篇 |
2001年 | 311574篇 |
2000年 | 309560篇 |
1999年 | 263163篇 |
1998年 | 103149篇 |
1997年 | 90176篇 |
1996年 | 84264篇 |
1995年 | 83147篇 |
1994年 | 75434篇 |
1993年 | 64458篇 |
1992年 | 182450篇 |
1991年 | 176843篇 |
1990年 | 171421篇 |
1989年 | 166354篇 |
1988年 | 153748篇 |
1987年 | 149769篇 |
1986年 | 142640篇 |
1985年 | 136001篇 |
1984年 | 103392篇 |
1983年 | 88616篇 |
1982年 | 56293篇 |
1979年 | 92723篇 |
1978年 | 66497篇 |
1977年 | 57207篇 |
1976年 | 53089篇 |
1975年 | 58179篇 |
1974年 | 67223篇 |
1973年 | 64156篇 |
1972年 | 59370篇 |
1971年 | 54982篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
Major depressive disorder is a serious and common neuropsychiatric disorder that affects more than 350 million people worldwide. Electroconvulsive therapy is the oldest and most effective treatment available for the treatment of severe major depressive disorder. Electroconvulsive therapy modifies structural network changes in patients with major depressive disorder and schizophrenia. And it can also affect neuroinflammatory responses and may have neuroprotective effects. Electroconvulsive therapy plays an irreplaceable role in the treatment of major depressive disorder. 相似文献
74.
75.
76.
Jos B. Poell Leon J. Wils Arjen Brink Ralf Dietrich Christine Krieg Eunike Velleuer Ilkay Evren Elisabeth R. Brouns Jan G. de Visscher Elisabeth Bloemena Bauke Ylstra Ruud H. Brakenhoff 《International journal of cancer. Journal international du cancer》2023,152(2):227-238
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia (OL) lesions. We developed a noninvasive genetic assay using next-generation sequencing (NGS) on brushed cells to detect the presence of genetically altered fields, including those that are not macroscopically visible. The assay demonstrated high accuracy in OL patients when brush samples were compared with biopsies as gold standard. In a cohort of Fanconi anemia patients, detection of mutations in prospectively collected oral brushes predicted oral cancer also when visible abnormalities were absent. We further provide insight in the molecular landscape of OL with frequent changes of TP53, FAT1 and NOTCH1. NGS analysis of noninvasively collected samples offers a highly accurate method to detect genetically altered fields in the oral cavity, and predicts development of OSCC in high-risk individuals. Noninvasive genetic screening can be employed to screen high-risk populations for cancer and precancer, map the extension of OL lesions beyond what is visible, map the oral cavity for precancerous changes even when visible abnormalities are absent, test accuracy of promising imaging modalities, monitor interventions and determine genetic progression as well as the natural history of the disease in the human patient. 相似文献
77.
78.
Biaoming Xu Yu Chen Mingjing Peng Jin Hai Zheng Chaohui Zuo 《International journal of cancer. Journal international du cancer》2023,152(2):110-122
Pancreatic cancer (PC) is a cancer of the digestive system, and pancreatic ductal adenocarcinoma (PDAC) accounts for approximately 90% of all PC cases. Exosomes derived from PDAC (PDAC-exosomes) promote PDAC development and metastasis. Exosomes are nanoscale vesicles secreted by most cells, which can carry biologically active molecules and mediate communication and cargo transportation among cells. Recent studies have focused on transforming exosomes into good drug delivery systems (DDSs) to improve the clinical treatment of PDAC. This review considers PDAC as the main research object to introduce the role of PDAC-exosomes in PDAC development and metastasis. This review focuses on the following two themes: (a) the great potential of PDAC-exosomes as new diagnostic markers for PDAC, and (b) the transformation of exosomes into potential DDSs. 相似文献
79.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
80.
Buket Bakan Fatih Oltulu Yeliz Y?ld?r?m Altu? Yava?o?lu Sinan Akg?l Nefise ülkü Karabay Yava?o?lu 《Arhiv za higijenu rada i toksikologiju》2023,74(3):207
The aim of this safety study in mice was to determine in vivo toxicity and biodistribution potential of a single and multiple doses of L-glutamic acid-g-p(HEMA) polymeric nanoparticles as a drug delivery system. The single dose did not cause any lethal effect, and its acute oral LD50 was >2.000 mg/kg body weight (bw). Multiple doses (25, 50, or 100 mg/kg bw) given over 28 days resulted in no significant differences in body and relative organ weights compared to control. These results are supported by biochemical and histological findings. Moreover, nanoparticle exposure did not result in statistically significant differences in micronucleus counts in bone marrow cells compared to control. Nanoparticle distribution was time-dependent, and they reached the organs and even bone marrow by hour 6, as established by ex vivo imaging with the IVIS® spectrum imaging system. In conclusion, L-glutamic acid-g-p(HEMA) polymeric nanoparticles appear biocompatible and have a potential use as a drug delivery system.KEY WORDS: biocompatibility, blood biochemistry, genotoxicity, histology, in vivo toxicity, micronucleus test, polymers 相似文献